The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes
Related Experiment Video
Updated: Mar 20, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Lomon So1, Jongdae Lee2, Miguel Palafox1
1Department of Molecular Biology and Biochemistry, and Institute for Immunology, University of California, Irvine, Irvine, CA 92697, USA.
Abstract:
Rapamycin has been used as a clinical immunosuppressant for many years; however, the molecular basis for its selective effects on lymphocytes remains unclear. We investigated the role of two canonical effectors of the mammalian target of rapamycin (mTOR): ribosomal S6 kinases (S6Ks) and eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BPs). S6Ks are thought to regulate cell growth (increase in cell size), and 4E-BPs are thought to control proliferation (increase in cell number), with mTORC1 signaling serving to integrate these processes. However, we found that the 4E-BP-eIF4E signaling axis controlled both the growth and proliferation of lymphocytes, processes for which the S6Ks were dispensable. Furthermore, rapamycin disrupted eIF4E function selectively in lymphocytes, which was due to the increased abundance of 4E-BP2 relative to that of 4E-BP1 in these cells and the greater sensitivity of 4E-BP2 to rapamycin. Together, our findings suggest that the 4E-BP-eIF4E axis is uniquely rapamycin-sensitive in lymphocytes and that this axis promotes clonal expansion of these cells by coordinating growth and proliferation.
Insights
Rapamycin targets the 4E-BP-eIF4E pathway in lymphocytes, controlling both cell growth and proliferation. This pathway, not S6Ks, is key to rapamycin's immunosuppressive effects on lymphocytes.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Rapamycin is a clinical immunosuppressant with unclear molecular mechanisms in lymphocytes.
- Mammalian target of rapamycin (mTOR) signaling involves effectors like S6 kinases (S6Ks) and 4E-binding proteins (4E-BPs).
- S6Ks are linked to cell growth, and 4E-BPs to proliferation, with mTORC1 integrating these functions.
Purpose of the Study:
- To elucidate the molecular basis of rapamycin's selective immunosuppressive effects on lymphocytes.
- To investigate the distinct roles of S6Ks and 4E-BPs in lymphocyte growth and proliferation.
- To determine the specific signaling axis responsible for rapamycin's action in lymphocytes.
Main Methods:
- Investigated the roles of S6Ks and 4E-BPs in lymphocyte signaling.
- Analyzed the impact of rapamycin on eIF4E function in lymphocytes.
- Assessed the relative abundance and sensitivity of 4E-BP1 and 4E-BP2 to rapamycin.
Main Results:
- The 4E-BP-eIF4E signaling axis, not S6Ks, controlled both lymphocyte growth and proliferation.
- Rapamycin selectively disrupted eIF4E function in lymphocytes.
- Increased 4E-BP2 abundance and its higher sensitivity to rapamycin were observed in lymphocytes.
Conclusions:
- The 4E-BP-eIF4E axis is uniquely sensitive to rapamycin in lymphocytes.
- This axis coordinates lymphocyte growth and proliferation, driving clonal expansion.
- Understanding this pathway offers insights into rapamycin's immunosuppressive action.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Cells Coordinate Growth and Proliferation

